South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Under the terms of the agreement, ADEL will receive an upfront payment of $80 million, with ?additional milestone ?payments tied to development progress and commercial performance, as well as ?royalties on future sales. Sanofi signed a separate deal with private biotech Dren Bio worth up ?to $1.7 billion on Monday to develop ?autoimmune disease therapies. ADEL's drug candidate, ADEL-Y01, is an antibody therapy designed to block harmful forms of a protein linked to Alzheimer's disease. It is currently in ?early-stage human trials in ?the United States. "ADEL's innovative ?approach to targeting tau acetylation offers a promising and differentiated mechanism ?for addressing ?the underlying causes of Alzheimer's disease," said Erik Wallstroem, global head, Multiple ?Sclerosis, Neurology and Gene Therapy Development at Sanofi. (Reporting ?by Sahil Pandey in Bengaluru; Editing ?by Sherry Jacob-Phillips)
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy [Yahoo! Finance]Yahoo! Finance
- Sanofi: Today's Tolebrutinib Setback Shouldn't Worry Shareholders - This Is Why [Seeking Alpha]Seeking Alpha
- Sanofi in deal worth up to $1.7B with Dren Bio for autoimmune disease treatments [Seeking Alpha]Seeking Alpha
- Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- 5 Things to Know Before the Stock Market Opens [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 12/15/25 - Form 6-K
- 12/12/25 - Form 6-K
- 12/3/25 - Form 6-K
- SNY's page on the SEC website